STAT3 phosphorylation in the rheumatoid arthritis immunological synapse

Area of Science:

• Immunology
• Molecular Biology
• Rheumatology

Background:

• The JAK/STAT pathway is a primary therapeutic target for Rheumatoid Arthritis (RA).
• JAK inhibitors are effective but some RA patients do not respond to them, necessitating alternative strategies.
• STAT3 activation is crucial in RA pathogenesis, but its regulation beyond JAK signaling is not fully understood.

Purpose of the Study:

• To identify novel, JAK-independent mechanisms of STAT3 activation in T cells.
• To investigate the role of the immunological synapse (IS) in STAT3 activation.
• To explore the potential of targeting this new pathway for RA treatment.

Main Methods:

• Investigated STAT3 activation in naïve CD4+ T cells upon immunological synapse formation.
• Utilized techniques to assess T cell receptor (TCR) dependent signaling.
• Analyzed the role of Lck kinase in STAT3 phosphorylation at the IS.
• Compared synaptic Lck/TCR-STAT3 pathway activity in RA patients and healthy controls.

Main Results:

• Identified a novel JAK-independent pathway for STAT3 activation initiated by immunological synapse formation.
• Demonstrated that Lck mediates TCR-dependent STAT3 phosphorylation at the IS in T cells.
• Showed that this synaptic Lck/TCR-STAT3 pathway is impaired in Rheumatoid Arthritis.
• Highlighted a previously unrecognized mechanism of early T cell activation.

Conclusions:

• A novel JAK-independent mechanism of STAT3 activation exists, mediated by Lck at the immunological synapse during T cell activation.
• The synaptic Lck/TCR-STAT3 pathway is compromised in Rheumatoid Arthritis.
• This pathway represents a potential new therapeutic target for RA, particularly for patients refractory to JAK inhibitors.